ngenla
pfizer europe ma eeig - somatrogon - growth and development - hipofiza in hypothalamic hormoni in analogi - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.
sapropterin dipharma
dipharma arzneimittel gmbh - sapropterin dihydrochloride - fenilketonurije - drugi zdravljene bolezni prebavil in presnove izdelki, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.
skytrofa (previously lonapegsomatropin ascendis pharma)
ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - hipofize in hipotalamični hormoni in analogi - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.
imdur 60 mg
tableta s podaljšanim sproščanjem - izosorbidmononitrat
iso mack retard 20 mg
kapsula s podaljšanim sproščanjem, trda - izosorbiddinitrat
isomonat 20
tableta - izosorbidmononitrat
lomilan retard tablete 20mg
tableta s podaljšanim sproščanjem - izosorbiddinitrat
lomilan tablete 5mg
tableta - izosorbiddinitrat
mono-5-wolff 20 mg
tableta - izosorbidmononitrat
mono-5-wolff 40 mg
tableta - izosorbidmononitrat